Obesity Pill from Eli Lilly Appears to Work as Well as Injected GLP-1s

Eli Lilly's new anti-obesity pill, orforglipron, shows comparable efficacy to injectable GLP-1 drugs like Ozempic for weight loss and blood sugar control, according to a Phase 3 trial.